Replies to post #159 on China Dom. Bio-tech Hldgs Inc. (fka CDBH)

[db7]

rcyt, on day of meuse 8k was at .10 .. ran as high as .35 afterwards


granted.. i'm hoping we have a longterm winner here

[redlepper]

general disarray

your inglorious campaign of incessant truth mirage into the irrelevant bash defines you as just another incessant nekkid short poster. probably a canuck too or maybe offshore south of the border. no red blooded american would bash any red blooded american enterprise. that is it, that is all.



red (blooded american?)

[Potse]

032798...CCKH/RCYT comparison......

"You could look at this stock for a comparison: RCYT. BP acquired over 97% of the stock a few months ago. Leaving approx 1.1M in the float. What is similar is the trading aspect b4 BP showed up on the scene. This is one of the worst non-r/s one's I've seen. Hopefully not the case here."

I think it may be a little difficult to use RCYT as a comparison stock. As I mentioned in a previous post Belmont Partners doesn't appear to use a strict "cookie cutter" kind of approach on the structuring of its deals, so the ultimate structure of the RM deals can vary quite a bit. Also, if I am correct in assuming a profitable China biotech/pharma is being vended into the CCKH shell, RCYT (housing design/manufacture) and CCKH (China biotech/pharma) will obviously have starkly different operating businesses which might influence general market/investor appeal. My hunch is that CCKH's RM business is probably going to be significantly more attractive on both a financial/fundamental and overall appeal basis.

However, if you do attempt to make a general comparison of the two stocks/situations I think it somewhat highlights how the CCKH shell is relatively attractive on a fundamental basis......

1) Rough market cap of the shells prior to Belmont purchasing control:

RCYT: $2.4M
CCKH: $700k

2) Rough market cap of the shells after Belmont purchased control, and prior to any additional transactions:

RCYT: $5-7M
CCKH: $700k

[temp luvs amy]

It is an interesting case study and gives you a feel for how BP does business. They don't seem to disclose many details. They marry the shell to a business, and then you have a new corporation from the old one.